Vyne Therapeutics Inc
General ticker "VYNE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $115.0M
Vyne Therapeutics Inc follows the US Stock Market performance with the rate: 22.6%.
Estimated limits based on current volatility of 6.7%: low 2.84$, high 3.25$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.73$, 4.35$]
- 2024-12-30 to 2025-12-30 estimated range: [1.56$, 3.79$]
Financial Metrics affecting the VYNE estimates:
- Negative: Non-GAAP EPS, $ of -6.87 <= 0.10
- Negative: Operating profit margin, % of -98.57 <= 1.03
- Negative: Operating cash flow per share per price, % of -44.86 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term VYNE quotes
Long-term VYNE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.93MM | $0.48MM | $0.42MM |
| Operating Expenses | $39.84MM | $34.77MM | $29.68MM |
| Operating Income | $-38.91MM | $-34.30MM | $-29.26MM |
| Non-Operating Income | $-5.75MM | $0.36MM | $1.39MM |
| Interest Expense | $5.61MM | $0.00MM | $0.00MM |
| R&D Expense | $24.96MM | $18.39MM | $16.31MM |
| Income(Loss) | $-44.66MM | $-33.93MM | $-27.87MM |
| Taxes | $-0.45MM | $0.01MM | $0.00MM |
| Other Income(Loss) | $-29.12MM | $10.73MM | $-0.58MM |
| Profit(Loss) | $-73.33MM | $-23.21MM | $-28.45MM |
| Stockholders Equity | $48.64MM | $31.20MM | $88.73MM |
| Inventory | $7.29MM | $0.10MM | $0.00MM |
| Assets | $67.05MM | $40.76MM | $97.69MM |
| Operating Cash Flow | $-56.37MM | $-29.20MM | $-25.34MM |
| Investing Cash Flow | $1.03MM | $15.67MM | $-57.35MM |
| Financing Cash Flow | $39.78MM | $1.65MM | $82.39MM |
| Earnings Per Share* | $-25.65 | $-10.65 | $-2.77 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.